Also trades as: MDCX (NASDAQ) · $vol 1M
MDCXW NASDAQ
Medicus Pharma Ltd. Common Stock
1W: -3.2%
1M: -22.7%
3M: -34.5%
YTD: -88.0%
1Y: -65.9%
$0.30
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$18M
-64.1% ▼
Net Income
-$25M
-127.4% ▼
EPS (Diluted)
$-1.96
-78.2% ▼
EBITDA
-$18M
-64.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $1M | $646K | $194K | $4M | $8M |
| SG&A Expenses | $258K | $332K | $5M | $8M | $18M |
| Operating Expenses | $1M | $978K | $5M | $11M | $18M |
| Operating Income | -$1M | -$978K | -$5M | -$11M | -$18M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $115K | $527K | $596K | $0 | $141K |
| Income Before Tax | -$2M | -$2M | -$5M | -$11M | -$25M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$2M | -$5M | -$11M | -$25M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.09 | $-0.34 | $-0.67 | $-0.90 | $-1.96 |
| EBITDA | -$2M | -$1M | -$5M | -$11M | -$18M |
| Shares Outstanding | 2M | 5M | 8M | 12M | 17M |